CD56 and RUNX1 isoforms in AML prognosis and their therapeutic potential
Neural cell adhesion molecule (NCAM/CD56) expression in acute myeloid leukemia (AML) has been associated with extramedullary leukemia, multidrug resistance, shorter remission and survival. Recently, Bloomfield et al. published a succinct review of issues surrounding the AML prognostication and curre...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Wolters Kluwer Medknow Publications
2016-07-01
|
| Edice: | Hematology/Oncology and Stem Cell Therapy |
| Témata: | |
| On-line přístup: | https://journals.lww.com/10.1016/j.hemonc.2015.11.006 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|